Literature DB >> 173996

Liver-cell adenomas associated with use of oral contraceptives.

H A Edmondson, B Henderson, B Benton.   

Abstract

During the past six years an increasing number of liver-cell adenomas in women were diagnosed, and we undertook a study of possible etiologic factors, including use of oral contraceptives, in 42 women. There was a significant difference between cases and matched controls in mean months of oral-contraceptive use: 73.4 as compared to 36.2 (P less than 0.001). The women with adenomas took mestranol-containing pills much more commonly than the controls (P less than 0.0001). Hemorrhage into the tumor was often associated with the onset of menstruation in women taking oral contraceptives. Long-term use of oral contraceptives, especially those containing a high total dose of steroids or mestranol as the synthetic estrogen, should be balanced against risks of side effects of the drugs.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 173996     DOI: 10.1056/NEJM197602262940904

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  100 in total

1.  Benign hepatic lesions in women taking oral contraceptives.

Authors:  T J Davis; R N Berk
Journal:  Gastrointest Radiol       Date:  1977-12-20

Review 2.  Focal nodular hyperplasia and hepatic adenoma: current diagnosis and management.

Authors:  Agustin Cristiano; Agustin Dietrich; Juan Carlos Spina; Victoria Ardiles; Eduardo de Santibañes
Journal:  Updates Surg       Date:  2013-06-27

Review 3.  Benign liver lesions: grey-scale and contrast-enhanced ultrasound appearances.

Authors:  A E Obaro; S M Ryan
Journal:  Ultrasound       Date:  2015-03-12

Review 4.  Liver adenomatosis: reappraisal, diagnosis, and surgical management: eight new cases and review of the literature.

Authors:  L Chiche; T Dao; E Salamé; M P Galais; N Bouvard; G Schmutz; P Rousselot; P Bioulac-Sage; P Ségol; M Gignoux
Journal:  Ann Surg       Date:  2000-01       Impact factor: 12.969

5.  Hepatocellular carcinoma coexisting with hepatic adenoma. Incidental discovery after long-term oral contraceptive use.

Authors:  J Korula; A Yellin; G Kanel; G Campofiori; P Nichols
Journal:  West J Med       Date:  1991-10

6.  Iso- or hyperintensity of hepatocellular adenomas on hepatobiliary phase does not always correspond to hepatospecific contrast-agent uptake: importance for tumor subtyping.

Authors:  Edouard Reizine; Maxime Ronot; Frederic Pigneur; Yvonne Purcell; Sebastien Mulé; Marco Dioguardi Burgio; Julien Calderaro; Giuliana Amaddeo; Alexis Laurent; Valérie Vilgrain; Alain Luciani
Journal:  Eur Radiol       Date:  2019-04-01       Impact factor: 5.315

Review 7.  Evaluation of nonmalignant liver masses.

Authors:  Wojciech Blonski; K Rajender Reddy
Journal:  Curr Gastroenterol Rep       Date:  2006-02

8.  Nuclear medicine: oral contraceptives, hepatic adenomas and liver scans.

Authors:  K Lyons
Journal:  West J Med       Date:  1977-06

9.  Liver cell adenoma showing sequential alteration of radiological findings suggestive of well-differentiated hepatocellular carcinoma.

Authors:  Takayuki Kogure; Yoshiyuki Ueno; Satoshi Sekiguchi; Kazuyuki Ishida; Takehiko Igarashi; Yuta Wakui; Takao Iwasaki; Tooru Shimosegawa
Journal:  World J Gastroenterol       Date:  2009-03-14       Impact factor: 5.742

10.  Structural modifications in contraceptive steroids altering their metabolism and toxicity.

Authors:  H M Bolt
Journal:  Arch Toxicol       Date:  1977-12-30       Impact factor: 5.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.